Ko, Eunkyung <br/><br/>
Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.  [electronic resource] 

 -  Annals of surgical oncology  Mar 2013 
 - 1005-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-012-2727-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Cadherins--metabolism<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Carcinoma, Squamous Cell--metabolism<br/>Cyclin A2--metabolism<br/>Cyclin D1--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Ki-67 Antigen--metabolism<br/>Lung Neoplasms--metabolism<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--metabolism<br/>Neoplasm Staging<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Retrospective Studies<br/>Survival Rate<br/>Tissue Array Analysis<br/>Tumor Suppressor Protein p53--metabolism